NRI

Cipla Ltd

Sector Pharmaceuticals
BSE 500087
NSE CIPLA
1,472.60
0.45 (0.03 %)
Buy
B
Sell
S
NSE BSE F&O

Overview

Day Low

1,472.15

Day High

1,480.15

52 Week Low

1,317.25

52 Week High

1,702.05

All Time Low

83.40

All Time High

1,702.05

Open

1,478.00

Close

1,472.15

Volume

34,016

Mkt cap (Cr)

118,929.24

P/E ratio

23.83

P/B ratio

0.24%

Div yield

0.88%

6M return

-7.00%

1Y return

1.02%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

1,472.60 0.03%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Cipla Ltd

Stock PE (TTM)

23.83

Promoter Holding

29.13%

Book Value

351.184

ROCE

22.27%

ROE

16.58%

Cipla Limited is a pharmaceutical company having a market capitalization of Rs. 73,307.57 crores as of 18th August 2021. The company was incorporated within the year 1935. It reported its consolidated revenue at Rs. 5,504.35 for the quarter ended June 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 500087 and scrip code CIPLA, respectively. As of 18th August 2021, the shares of Cipla were trading at Rs. 908.85.

Cipla is headquartered in Mumbai and produces products for various therapeutic areas, including cardiology, children’s health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious illnesses & critical care, malaria, and so on. The drug company primarily develops medicines to treat respiratory, disorders, arthritis, diabetes, weight control and depression, and other medical conditions. Cipla is the third-largest drug company within the country and is present in most countries within the European region, with DTMs in Germany, Norway, UK, and Spain. The company’s promoters hold a 36.72% stake of the total shareholding in the company in June 2021 as against 36.68% in June 2020 with zero pledge. However, the mutual funds holding has also decreased in the last 12 months, decreasing from 16.29% in June 2020 to 13.36% in June 2021, and over the last 3 months, it has decreased 1.28%.

In June 2021, consolidated total revenue from operations grew 26.64% to Rs. 5,504.35 crores, against Rs. 4,346.16 crores within the corresponding quarter last year. The Indian major pharmaceutical has posted a 23.67% increase in the consolidated net profit of Rs. 714.72 crores, on strong sales performance during June 2021, it had posted a net profit of Rs. 577.91 Crores within the corresponding period of the previous fiscal. EBITDA rose 28% to Rs. 1,346 crores in June 2021, from Rs. 1,049 crores in June 2020. EBITDA margin improved 32 basis points to 24.5%, as against 24.1% in the year-ago period. EPS of the company was Rs. 8.86 as compared to Rs. 5.13 in March 2021. Cipla’s shares closed at 908.85 (NSE) on 18th August 2021 and have returned 18.83% over the last 12 months.

Cipla share price as on 14 Feb 2025 is Rs. 1472.6. Over the past 6 months, the Cipla share price has decreased by 7% and in the last one year, it has increased by 1.02%. The 52-week low for Cipla share price was Rs. 1317.25 and 52-week high was Rs. 1702.05.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

500087

CIPLA

INE059A01026

Aug

Cipla Ltd FAQs

You can buy Cipla Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Cipla Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Feb 14, 2025 09:19 AM the closing price of Cipla Ltd was Rs.1,472.60.

The latest PE ratio of Cipla Ltd as of Feb 14, 2025 09:19 AM is 23.83

The latest PB ratio of Cipla Ltd as of Feb 14, 2025 09:19 AM is 0.24

The 52-week high of Cipla Ltd share price is Rs. 1,702.05 while the 52-week low is Rs. 1,317.25

According to analyst recommendations, Cipla Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Feb 14, 2025 09:19 AM, the market cap of Cipla Ltd stood at Rs. 118,929.24 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.